Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction

Cardiol J. 2019;26(1):102-104. doi: 10.5603/CJ.2019.0016.

Authors

Alicja Dąbrowska-Kugacka¹, Dariusz Ciećwierz², Grzegorz Żuk², Marcin Fijałkowski², Antoni Ottowicz³, Joanna Kwiatkowska⁴, Ewa Lewicka⁵, Robert Sabiniewicz⁴

Affiliations

¹ Department of Cardiology and Electrotherapy, Medical University of Gdansk, Poland. [email protected].
² Department of Cardiology, Medical University of Gdansk, Poland.
³ Department of Anesthesiology and Intensive Care, Medical University of Gdansk, Poland.
⁴ Department of Pediatric Cardiology and Congenital Heart Disease, Medical University of Gdansk, Poland.
⁵ Department of Cardiology and Electrotherapy, Medical University of Gdansk, Poland.

No abstract available

Publication types

Case Reports
Letter
Video-Audio Media

MeSH terms

Adult
Antihypertensive Agents / therapeutic use*
Blood Flow Velocity / physiology*
Cardiac Surgical Procedures / methods*
Drug Resistance*
Echocardiography, Transesophageal
Heart Atria / diagnostic imaging
Heart Atria / physiopathology*
Heart Septal Defects, Atrial / complications
Heart Septal Defects, Atrial / surgery*
Humans
Hypertension, Pulmonary / drug therapy
Hypertension, Pulmonary / physiopathology
Hypertension, Pulmonary / therapy*
Male
Septal Occluder Device

Substances

Antihypertensive Agents